| 0.5 |
1.4 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 |
1.1 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.3 |
1.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 |
0.8 |
GO:0002728 |
negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.3 |
0.8 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.2 |
1.2 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 |
0.6 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.2 |
0.6 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.2 |
0.7 |
GO:2000729 |
positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.2 |
0.9 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 |
0.5 |
GO:1903625 |
L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.4 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 |
0.6 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 |
0.5 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.7 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.5 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.4 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
0.4 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.1 |
0.3 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.1 |
0.7 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.3 |
GO:0070173 |
regulation of enamel mineralization(GO:0070173) |
| 0.1 |
0.2 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
1.8 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.3 |
GO:0060775 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.1 |
0.3 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.9 |
GO:0032277 |
negative regulation of gonadotropin secretion(GO:0032277) |
| 0.1 |
1.9 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.4 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
1.0 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.2 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 |
0.8 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
0.2 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
0.6 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.2 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 |
1.0 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.9 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.2 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.2 |
GO:0060931 |
sinoatrial node cell development(GO:0060931) |
| 0.1 |
0.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
0.4 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.3 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.3 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.2 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.2 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.1 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
0.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.3 |
GO:1904209 |
regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.1 |
0.2 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.1 |
2.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0071288 |
cellular response to mercury ion(GO:0071288) |
| 0.0 |
0.2 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 |
0.1 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.0 |
0.2 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
1.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.4 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.2 |
GO:2000809 |
positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.0 |
0.2 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.0 |
0.0 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.0 |
0.4 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.1 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
0.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.3 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 |
0.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.2 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.2 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.0 |
0.5 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.2 |
GO:1904396 |
regulation of neuromuscular junction development(GO:1904396) |
| 0.0 |
0.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.1 |
GO:0007402 |
ganglion mother cell fate determination(GO:0007402) |
| 0.0 |
0.3 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 |
0.1 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 |
0.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.1 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.0 |
0.1 |
GO:0003358 |
noradrenergic neuron development(GO:0003358) |
| 0.0 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.2 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.0 |
0.1 |
GO:0071484 |
response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
| 0.0 |
0.2 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.0 |
0.1 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.0 |
0.3 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.0 |
0.2 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.5 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.1 |
GO:2000334 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.0 |
0.1 |
GO:0035948 |
N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.0 |
0.1 |
GO:0072708 |
response to sorbitol(GO:0072708) cellular response to sorbitol(GO:0072709) |
| 0.0 |
0.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.2 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.1 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.0 |
0.3 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.0 |
0.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.1 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.0 |
0.2 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.0 |
0.2 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.0 |
0.0 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.0 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.1 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.0 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.0 |
0.2 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.0 |
0.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.0 |
0.1 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.0 |
GO:0043324 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.1 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 |
0.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.1 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.2 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
0.1 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.0 |
0.1 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.0 |
0.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.0 |
2.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.0 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.5 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 |
0.1 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.1 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 |
0.2 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.4 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.1 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
| 0.0 |
0.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.1 |
GO:0031936 |
DNA replication-dependent nucleosome assembly(GO:0006335) negative regulation of chromatin silencing(GO:0031936) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.3 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.1 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.3 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.1 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.3 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.6 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.0 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.8 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.0 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.0 |
0.1 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.0 |
0.3 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.4 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 |
0.1 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.3 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.1 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.0 |
0.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
